U.S. PHYSICAL THERAPY INC (USPH) Stock Fundamental Analysis
NYSE:USPH - New York Stock Exchange, Inc. - US90337L1089 - Common Stock - Currency: USD
Taking everything into account, USPH scores 5 out of 10 in our fundamental rating. USPH was compared to 107 industry peers in the Health Care Providers & Services industry. USPH has only an average score on both its financial health and profitability. USPH is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year USPH was profitable.
USPH had a positive operating cash flow in the past year.
In the past 5 years USPH has always been profitable.
In the past 5 years USPH always reported a positive cash flow from operatings.
1.2 Ratios
USPH has a better Return On Assets (2.38%) than 63.55% of its industry peers.
USPH has a Return On Equity of 5.67%. This is in the better half of the industry: USPH outperforms 64.49% of its industry peers.
The Return On Invested Capital of USPH (4.98%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for USPH is below the industry average of 8.16%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.38% | ||
| ROE | 5.67% | ||
| ROIC | 4.98% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
1.3 Margins
USPH's Profit Margin of 4.13% is fine compared to the rest of the industry. USPH outperforms 78.50% of its industry peers.
In the last couple of years the Profit Margin of USPH has declined.
USPH has a Operating Margin of 10.32%. This is amongst the best in the industry. USPH outperforms 85.05% of its industry peers.
In the last couple of years the Operating Margin of USPH has declined.
With a Gross Margin value of 19.01%, USPH is not doing good in the industry: 64.49% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of USPH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.32% | ||
| PM (TTM) | 4.13% | ||
| GM | 19.01% |
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
2. Health
2.1 Basic Checks
USPH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for USPH has been increased compared to 1 year ago.
Compared to 5 years ago, USPH has more shares outstanding
Compared to 1 year ago, USPH has an improved debt to assets ratio.
2.2 Solvency
USPH has an Altman-Z score of 2.15. This is not the best score and indicates that USPH is in the grey zone with still only limited risk for bankruptcy at the moment.
USPH has a Altman-Z score of 2.15. This is comparable to the rest of the industry: USPH outperforms 52.34% of its industry peers.
USPH has a debt to FCF ratio of 2.33. This is a good value and a sign of high solvency as USPH would need 2.33 years to pay back of all of its debts.
USPH's Debt to FCF ratio of 2.33 is amongst the best of the industry. USPH outperforms 80.37% of its industry peers.
USPH has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
USPH has a better Debt to Equity ratio (0.29) than 63.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 2.33 | ||
| Altman-Z | 2.15 |
ROIC/WACC0.59
WACC8.38%
2.3 Liquidity
USPH has a Current Ratio of 1.18. This is a normal value and indicates that USPH is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.18, USPH is not doing good in the industry: 66.36% of the companies in the same industry are doing better.
A Quick Ratio of 1.18 indicates that USPH should not have too much problems paying its short term obligations.
USPH's Quick ratio of 1.18 is in line compared to the rest of the industry. USPH outperforms 41.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 0.78% over the past year.
USPH shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.76% yearly.
USPH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.00%.
USPH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.85% yearly.
EPS 1Y (TTM)0.78%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%10.17%
Revenue 1Y (TTM)11%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%16.57%
3.2 Future
The Earnings Per Share is expected to grow by 12.87% on average over the next years. This is quite good.
USPH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.94% yearly.
EPS Next Y13.92%
EPS Next 2Y12.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.55%
Revenue Next 2Y8.94%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 31.33 indicates a quite expensive valuation of USPH.
USPH's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of USPH to the average of the S&P500 Index (29.35), we can say USPH is valued inline with the index average.
The Price/Forward Earnings ratio is 27.51, which means the current valuation is very expensive for USPH.
USPH's Price/Forward Earnings is on the same level as the industry average.
USPH is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.33 | ||
| Fwd PE | 27.51 |
4.2 Price Multiples
USPH's Enterprise Value to EBITDA ratio is in line with the industry average.
72.90% of the companies in the same industry are more expensive than USPH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.68 | ||
| EV/EBITDA | 15.23 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates USPH does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as USPH's earnings are expected to grow with 12.87% in the coming years.
PEG (NY)2.25
PEG (5Y)N/A
EPS Next 2Y12.87%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.17%, USPH has a reasonable but not impressive dividend return.
USPH's Dividend Yield is rather good when compared to the industry average which is at 3.11. USPH pays more dividend than 91.59% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, USPH has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.17% |
5.2 History
The dividend of USPH is nicely growing with an annual growth rate of 9.09%!
USPH has been paying a dividend for at least 10 years, so it has a reliable track record.
USPH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.09%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
USPH pays out 95.72% of its income as dividend. This is not a sustainable payout ratio.
USPH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP95.72%
EPS Next 2Y12.87%
EPS Next 3YN/A
80.84
-2.14 (-2.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners106.01%
Inst Owner Change3.39%
Ins Owners1.44%
Ins Owner Change9.6%
Market Cap1.23B
Analysts84.62
Price Target116.79 (44.47%)
Short Float %3.4%
Short Ratio4.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.17% |
Yearly Dividend1.76
Dividend Growth(5Y)9.09%
DP95.72%
Div Incr Years4
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.32%
Min EPS beat(2)-7.64%
Max EPS beat(2)-1%
EPS beat(4)0
Avg EPS beat(4)-7.91%
Min EPS beat(4)-12.54%
Max EPS beat(4)-1%
EPS beat(8)2
Avg EPS beat(8)-3.16%
EPS beat(12)4
Avg EPS beat(12)-2.52%
EPS beat(16)8
Avg EPS beat(16)2.66%
Revenue beat(2)2
Avg Revenue beat(2)0.72%
Min Revenue beat(2)0.22%
Max Revenue beat(2)1.22%
Revenue beat(4)3
Avg Revenue beat(4)0.48%
Min Revenue beat(4)-0.48%
Max Revenue beat(4)1.22%
Revenue beat(8)5
Avg Revenue beat(8)0.43%
Revenue beat(12)6
Avg Revenue beat(12)-0.22%
Revenue beat(16)7
Avg Revenue beat(16)-0.25%
PT rev (1m)-0.43%
PT rev (3m)9.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.5%
EPS NY rev (1m)0%
EPS NY rev (3m)0.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)-0.75%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.33 | ||
| Fwd PE | 27.51 | ||
| P/S | 1.83 | ||
| P/FCF | 18.68 | ||
| P/OCF | 16.39 | ||
| P/B | 2.51 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.23 |
EPS(TTM)2.58
EY3.19%
EPS(NY)2.94
Fwd EY3.64%
FCF(TTM)4.33
FCFY5.35%
OCF(TTM)4.93
OCFY6.1%
SpS44.2
BVpS32.19
TBVpS-23.54
PEG (NY)2.25
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.38% | ||
| ROE | 5.67% | ||
| ROCE | 6.59% | ||
| ROIC | 4.98% | ||
| ROICexc | 5.19% | ||
| ROICexgc | 32.06% | ||
| OM | 10.32% | ||
| PM (TTM) | 4.13% | ||
| GM | 19.01% | ||
| FCFM | 9.79% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
ROICexc(3y)6.35%
ROICexc(5y)7.3%
ROICexgc(3y)37.05%
ROICexgc(5y)44.29%
ROCE(3y)7.65%
ROCE(5y)8.96%
ROICexcg growth 3Y-11.04%
ROICexcg growth 5Y-7.52%
ROICexc growth 3Y-14.51%
ROICexc growth 5Y-13.29%
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
F-Score5
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 2.33 | ||
| Debt/EBITDA | 1.62 | ||
| Cap/Depr | 49.17% | ||
| Cap/Sales | 1.37% | ||
| Interest Coverage | 9.61 | ||
| Cash Conversion | 85.17% | ||
| Profit Quality | 237.14% | ||
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 2.15 |
F-Score5
WACC8.38%
ROIC/WACC0.59
Cap/Depr(3y)54.79%
Cap/Depr(5y)61.53%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.57%
Profit Quality(3y)269.82%
Profit Quality(5y)263.85%
High Growth Momentum
Growth
EPS 1Y (TTM)0.78%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%10.17%
EPS Next Y13.92%
EPS Next 2Y12.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%16.57%
Revenue Next Year11.55%
Revenue Next 2Y8.94%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.44%
EBIT growth 3Y-0.34%
EBIT growth 5Y0.76%
EBIT Next Year35.87%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-9.53%
FCF growth 3Y-1.21%
FCF growth 5Y4.7%
OCF growth 1Y-8.59%
OCF growth 3Y-0.65%
OCF growth 5Y3.71%